Comfort-focused care at the end of life: pain, breathlessness, agitation and secretions, and how to withdraw ventilation humanely.
At the bedside
- 1
Assess symptoms
Pain (CPOT/BPS), breathlessness (respiratory rate, accessory muscle use, grimacing), agitation, secretions; repeat at least hourly during withdrawal.
- 2
Stop non-beneficial interventions
Routine bloods, imaging, monitoring alarms, vasopressors, RRT, NG feeding that adds no comfort; keep mouth care, positioning and skin care.
- 3
Pain and breathlessness
Opioid (morphine or fentanyl) bolus and infusion titrated to comfort; fan and positioning.
- 4
Anxiety and agitation
Midazolam boluses/infusion; exclude urinary retention and pain.
- 5
Secretions
Reposition; glycopyrronium or hyoscine butylbromide; gentle oral suction; explain to family.
- 6
Compassionate extubation
Prepare family; premedicate (opioid ± midazolam) before extubation; stop neuromuscular blockers well before (must have worn off); reduce FiO₂/support then extubate to air or low-flow oxygen; treat distress immediately.
- 7
After death
Allow family time and rituals; bereavement support; complete death certification.
Breathlessness or pain
Morphine
- Dose
- 1-2 mg IV (2.5-5 mg SC) as needed; infusion 0.5-2 mg/h
- Worked example
- 70 kg opioid-naive: morphine 2 mg IV before extubation, then 1 mg/h infusion with 2 mg boluses for respiratory distress.
Anxiety, agitation
Midazolam
- Dose
- 1-2 mg IV (2.5-5 mg SC) as needed; infusion 0.5-2 mg/h
Respiratory secretions
Glycopyrronium (glycopyrrolate)
- Dose
- 200 mcg every 4-6 h as needed
Respiratory secretions (alternative)
Hyoscine butylbromide
- Dose
- 20 mg every 4 h as needed (max 120 mg/24 h)
Pathophysiology
Dyspnoea results from mismatch between respiratory drive and achieved ventilation; opioids reduce the perception of breathlessness and respiratory drive. Secretions pool in the oropharynx when swallowing and cough fail.
Evidence
- ACCM end-of-life care recommendations [Truog 2008].
- NICE NG31 care of dying adults [NICE 2015]; review of dying in ICU [Cook 2014].
Controversies
- Terminal extubation versus terminal weaning; palliative sedation depth.
🇮🇳 India notes
- Morphine access in India is limited by NDPS regulations although simplified since 2014 amendments; ensure the hospital holds a licence and stock (recognised medical institution status).
- Palliative care teams are available in larger centres; ISCCM/IAPC encourage integration with ICU.
References
Test yourself
Module quiz · score 70% to complete the module
Previous
Withholding and withdrawing treatment in India (law and process)
Next
Organ donation: the request conversation
Educational reference for trained clinicians. Check doses against your hospital protocol and the patient in front of you.

